Join investingLive News Updates
Join investingLive FX & Crypto
Follow us on Twitter
Follow Us on Facebook
MSTR jumped 12% on Bitcoin's rally past $76k. It's a leveraged play, but watch for downside risk.
AI drug trials startup hits $1.8B valuation. Betting on faster clinical trials, it aims to cut drug development risks and costs.
ARLO jumps 3.6% on Strait of Hormuz reopening, but still 21% below 52-week high.
Cerebras eyes $35B+ IPO valuation, fueled by AI boom & OpenAI deal. Risk: competition.
Insider buys $2M MNR units near $13.05, near $12.77 close. 15% dividend yield.
Goldman Sachs sees balanced oil risks, keeping 2026 Brent at $83, WTI at $78. Demand weakness adds downside.
SpaceX's $2T IPO looms, but history shows IPOs often underperform. Meta soared, but Rivian tanked. Wait for dips.
Sponsored
Economic Calendar
Access key global economic events & real-time data releases.
Live Charts
View real-time price charts.
Live Quotes
Get instant price updates for forex, commodities, stocks, etc.
Must Read